Phenotypic screening unleashed by morphology
Add a new dimension to your phenotypic screens with the exhaustive capacity of morphological profiling. Compatible with both small molecule screens and CRISPR-based approaches, VisionSort opens the door to a wider range of phenotypes to screen.
Discover new drugs and drug targets quickly and more efficiently with VisionSort.
White Paper
Webinar
Webinar
App Note
Webinar (JPN/日本語)
Webinar
APP NOTE
APP NOTE
Identification of disease relevant phenotypes in phenotypic drug screening is critical. With VisionSort, unlock to potential to screen for a wider range of phenotypes from global cell states like metabolic activity and differentiation state to molecular transitions including changes in protein localization, aggregation, or organelle localization. VisionSort’s high-resolution profiling detects subtle morphological differences in cells and enables drug developers to find new candidates faster.
Diverse library compatibility, including CRISPR gRNAs, shRNAs, antibodies, peptides, & small molecule compounds
Pathway-specific libraries: 1-3h
Whole genome libraries: 8-12 h
Compound libraries: 1-3 d
Only a few hundred cells per gene or compound are needed for screening
Directly link genotypes to phenotypes in any screen
High-content drug screening with VisionSort can accelerate the screening process and reduce costs. Supporting flexible workflows, VisionSort is driving the next generation of modern phenotypic drug discovery programs.
1100 Island Drive STE 203
Redwood City, CA 94065
7-3-1 Hongo, Bunkyo, Tokyo
シンクサイト株式会社
東京都文京区本郷7-3-1
